Cargando…

Can Cytokine Blocking Prevent Depression in COVID-19 Survivors?

Detalles Bibliográficos
Autores principales:	Benedetti, Francesco, Mazza, Mario, Cavalli, Giulio, Ciceri, Fabio, Dagna, Lorenzo, Rovere-Querini, Patrizia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587545/ https://www.ncbi.nlm.nih.gov/pubmed/33107012 http://dx.doi.org/10.1007/s11481-020-09966-z

Ejemplares similares

Correction to: Can Cytokine Blocking Prevent Depression in COVID-19 Survivors?
por: Benedetti, Francesco, et al.
Publicado: (2021)

Mood-congruent negative thinking styles and cognitive vulnerability in depressed COVID-19 survivors: A comparison with major depressive disorder
por: Benedetti, Francesco, et al.
Publicado: (2022)

Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors
por: Mazza, Mario Gennaro, et al.
Publicado: (2020)

One-year mental health outcomes in a cohort of COVID-19 survivors
por: Mazza, Mario Gennaro, et al.
Publicado: (2022)

Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up
por: Mazza, Mario Gennaro, et al.
Publicado: (2021)

Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life
por: Poletti, Sara, et al.
Publicado: (2021)

Lower levels of glutathione in the anterior cingulate cortex associate with depressive symptoms and white matter hyperintensities in COVID-19 survivors
por: Poletti, Sara, et al.
Publicado: (2022)

The Burden of Survivorship: Survivor Guilt and Its Association with Psychiatric Sequelae in COVID-19 Patients
por: Palladini, Mariagrazia, et al.
Publicado: (2023)

P.0691 Mood-congruent cognitive distortion and processing bias in depressed covid-19 survivors: a comparison with major depressive disorder
por: Palladini, M., et al.
Publicado: (2021)

Rapid response to selective serotonin reuptake inhibitors in post-COVID depression
por: Mazza, Mario Gennaro, et al.
Publicado: (2022)

Brain correlates of depression, post-traumatic distress, and inflammatory biomarkers in COVID-19 survivors: A multimodal magnetic resonance imaging study
por: Benedetti, Francesco, et al.
Publicado: (2021)

A Nomogram-Based Model to Predict Respiratory Dysfunction at 6 Months in Non-Critical COVID-19 Survivors
por: De Lorenzo, Rebecca, et al.
Publicado: (2022)

Brain correlates of subjective cognitive complaints in COVID-19 survivors: A multimodal magnetic resonance imaging study
por: Paolini, Marco, et al.
Publicado: (2023)

The course of action for effective anti-cytokine treatment in COVID-19
por: Cavalli, Giulio, et al.
Publicado: (2021)

Prevalence, trajectory over time, and risk factor of post-COVID-19 fatigue
por: Mazza, Mario Gennaro, et al.
Publicado: (2022)

Neural underpinnings of subjective cognitive impairment in COVID-19 survivors
por: Paolini, M., et al.
Publicado: (2022)

The exploration of interoception construct in COVID-19 survivors
por: D’Orsi, G., et al.
Publicado: (2023)

P.0267 Persistent psychopathology in covid-19 survivors at one-year follow-up
por: Mazza, M.G., et al.
Publicado: (2021)

Interoception accuracy and awareness in COVID-19 survivors – an exploratory study.
por: D'Orsi, G., et al.
Publicado: (2022)

Subjective cognitive decline after the Sars-CoV-2 infection affects white matter microstructure in COVID-19 survivors
por: Palladini, M., et al.
Publicado: (2022)

Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation
por: Della-Torre, Emanuel, et al.
Publicado: (2021)

The elusive role of proton pump inhibitors in COVID-19: Can plasma Chromogranin A levels hold the key?
por: Sciorati, Clara, et al.
Publicado: (2023)

Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis
por: Ciceri, Fabio, et al.
Publicado: (2023)

Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study
por: Della-Torre, Emanuel, et al.
Publicado: (2020)

Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study
por: Cavalli, Giulio, et al.
Publicado: (2021)

Inflammatory signature of post-COVID-19 depression
por: Palladini, M., et al.
Publicado: (2023)

A virus-free cellular model recapitulates several features of severe COVID-19
por: Lavorgna, Giovanni, et al.
Publicado: (2021)

Dysglycemia after COVID-19 pneumonia: a six-month cohort study
por: Molinari, Chiara, et al.
Publicado: (2021)

Effect of anakinra in COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Large-scale use of hydroxychloroquine for COVID-19 confirms safety, if not effectiveness
por: Cavalli, Giulio, et al.
Publicado: (2020)

The right place for IL-1 inhibition in COVID-19
por: Cavalli, Giulio, et al.
Publicado: (2021)

505. Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study
por: Spagnuolo, Vincenzo, et al.
Publicado: (2021)

Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study
por: Spagnuolo, Vincenzo, et al.
Publicado: (2022)

Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients
por: De Lorenzo , Rebecca, et al.
Publicado: (2021)

COVID-19: Pharmacology and kinetics of viral clearance
por: Farina, Nicola, et al.
Publicado: (2020)

GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study
por: De Luca, Giacomo, et al.
Publicado: (2020)

Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study
por: Campochiaro, Corrado, et al.
Publicado: (2020)

Begelomab for severe refractory dermatomyositis: A case report
por: De Lorenzo, Rebecca, et al.
Publicado: (2021)

Low Vitamin D Levels Are Associated With Long COVID Syndrome in COVID-19 Survivors
por: di Filippo, Luigi, et al.
Publicado: (2023)

Chitinase-3-like protein-1 at hospital admission predicts COVID-19 outcome: a prospective cohort study
por: De Lorenzo, Rebecca, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s1rriop4srpnajpvu9o6q1lcrp